The 20 Best Graft Versus Host Disease (GvHD) Doctors Near Me

David Avigan is an Internal Medicine specialist and an Oncologist in Boston, Massachusetts. Dr. Avigan is rated as an Elite provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). His top areas of expertise are Multiple Myeloma, Acute Myeloid Leukemia (AML), Non-Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.

Robert Soiffer is an Oncologist in Boston, Massachusetts. Dr. Soiffer is rated as an Elite provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). His top areas of expertise are Graft Versus Host Disease (GvHD), Hepatic Venoocclusive Disease with Immunodeficiency, Chronic Graft Versus Host Disease (cGvHD), Bone Marrow Transplant, and Bone Graft.

Georg Schett practices in Erlangen, Germany. Mr. Schett is rated as an Elite expert by MediFind in the treatment of Graft Versus Host Disease (GvHD). His top areas of expertise are Arthritis, Psoriatic Arthritis, Rheumatoid Arthritis (RA), Oophorectomy, and Lithotripsy.

Paul Emery practices in Leeds, United Kingdom. Mr. Emery is rated as an Elite expert by MediFind in the treatment of Graft Versus Host Disease (GvHD). His top areas of expertise are Rheumatoid Arthritis (RA), Arthritis, Synovitis, and Palindromic Rheumatism.

Oliver Distler practices in Zurich, Switzerland. Mr. Distler is rated as an Elite expert by MediFind in the treatment of Graft Versus Host Disease (GvHD). His top areas of expertise are Systemic Sclerosis (SSc), Scleroderma, Acute Interstitial Pneumonia, Lung Transplant, and Bone Marrow Transplant.

Amelia Langston is a Hematologist Oncology provider in Atlanta, Georgia. Dr. Langston has been practicing medicine for over 42 years and is rated as a Distinguished provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). Her top areas of expertise are Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), Aplastic Anemia, Bone Marrow Transplant, and Bone Marrow Aspiration.

Jacalyn Rosenblatt is an Internal Medicine provider in Boston, Massachusetts. Dr. Rosenblatt is rated as a Distinguished provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). Her top areas of expertise are Multiple Myeloma, Acute Myeloid Leukemia (AML), Smoldering Multiple Myeloma, Bone Marrow Aspiration, and Bone Marrow Transplant.

Dr. Pulsipher is currently the Division Chief of the Pediatric Hematology at Intermountain Primary Children's Hospital and Oncology, Director of the Children's and Adolescent Cancer Initiative at Huntsman Cancer Institute and a Presidential Chair in Pediatric Oncology and Hematology at the University of Utah.  Dr. Pulsipher is an internationally recognized expert in Bone Marrow Transplantation and Cellular Therapy, having directed the world's largest pediatric transplant research group for more than a decade (Pediatric Transplantation and Cellular Therapy Consortium).  He has run more than 20 multicenter trials in the field and is considered and expert in broad areas of transplantation and cellular therapy.  Areas of focus have included development of reduced toxicity approaches to transplantation of both malignant and non-malignant disorders with a focus on minimizing short and long-term effects of transplant.  For non-malignant disorders he has run national protocols that have improved safety for patients with immunodeficiencies, HLH, and bone marrow failure. For cancer, he has developed techniques allowing identification of patients who can avoid radiation-based treatments for leukemia.  This has included a novel approach to safer transplantation of patients using half-matched family donors (haploidentical donors) using a novel form of bone marrow graft engineering called alpha-beta T-cell depletion.  His desire to develop safer approaches has become a major focus as he has led major studies in the field of chimeric antigen receptor T-cells (CAR T-cells), a safer approach to cancer cure.  Dr. Pulsipher's work in cell therapy helped lead to the FDA approval of the first CART cell treatment, tisagenlecleucel, and he continues to run trials in CAR T, NK, and Viral Specific T-cell therapies. He has open protocols aimed at improving outcomes and his lab efforts are focused on making CAR T-cells that last longer and avoid overcome resistance by cancer cells. Dr. Pulsipher's interests have included ensuring that the families of those undergoing transplantation and cell therapy are psychologically well throughout the process.  To help with this, he has run several large trials assessing the safety and Quality of Life of pediatric bone marrow donors and is he currently running a large national trial looking at the psychological well-being of donor and recipient families as they go through the transplant process.For questions regarding Dr. Pulsipher's adult practice at the Huntsman Cancer Institute, or for questions about any of our clinical programs and for assistance identifying the right Hematology specialist for you or your family member, please contact our Clinical Care Specialist/New Patient Coordinator at (801) 587-4652. For questions regarding Dr. Pulsipher's pediatric practice and the Blood and Marrow Transplant Program at Primary Children's Medical Center, please call (801) 662-4830. Dr. Pulsipher is rated as a Distinguished provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Graft Versus Host Disease (GvHD), Leukemia, Severe Combined Immunodeficiency (SCID), and Bone Marrow Transplant.

Bruce Blazar is a Hematologist and an Oncologist in Minneapolis, Minnesota. Dr. Blazar is rated as a Distinguished provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). His top areas of expertise are Chronic Graft Versus Host Disease (cGvHD), Graft Versus Host Disease (GvHD), Leukemia, Congenital Aplastic Anemia, and Bone Marrow Transplant.

Masao Tanaka practices in Kyoto, Japan. Mr. Tanaka is rated as a Distinguished expert by MediFind in the treatment of Graft Versus Host Disease (GvHD). His top areas of expertise are Rheumatoid Arthritis (RA), Pancreatic Cancer, Arthritis, Pancreatectomy, and Pancreaticoduodenectomy.

Muna Qayed is a Hematologist and an Oncologist in Atlanta, Georgia. Dr. Qayed is rated as a Distinguished provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). Her top areas of expertise are Graft Versus Host Disease (GvHD), Acute Lymphoblastic Leukemia (ALL), Chronic Graft Versus Host Disease (cGvHD), Leukemia, and Bone Marrow Transplant.

Christine Falk practices in Hannover, Germany. Ms. Falk is rated as a Distinguished expert by MediFind in the treatment of Graft Versus Host Disease (GvHD). Her top areas of expertise are Severe Acute Respiratory Syndrome (SARS), Cytomegalovirus Infection, Hepatitis, Lung Transplant, and Kidney Transplant.

Bodo Grimbacher practices in Hannover, Germany. Grimbacher is rated as a Distinguished expert by MediFind in the treatment of Graft Versus Host Disease (GvHD). Their top areas of expertise are Common Variable Immune Deficiency, Hyper IgE Syndrome, Autosomal Dominant Hyper IgE Syndrome, Primary Immunodeficiency (PID), and Bone Marrow Transplant.

Elisabetta Miserocchi practices in Milan, Italy. Ms. Miserocchi is rated as a Distinguished expert by MediFind in the treatment of Graft Versus Host Disease (GvHD). Her top areas of expertise are Uveitis, Juvenile Idiopathic Arthritis (JIA), Punctate Inner Choroidopathy, Vitrectomy, and Gamma Knife Radiosurgery.

Klaus Warnatz practices in Freiburg, Germany. Mr. Warnatz is rated as a Distinguished expert by MediFind in the treatment of Graft Versus Host Disease (GvHD). His top areas of expertise are Common Variable Immune Deficiency, Primary Immunodeficiency (PID), X-Linked Agammaglobulinemia, Severe Combined Immunodeficiency (SCID), and Bone Marrow Transplant.

Christine Duncan is a Hematologist and an Oncologist in Boston, Massachusetts. Dr. Duncan is rated as a Distinguished provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). Her top areas of expertise are Adrenoleukodystrophy (ALD), Hepatic Venoocclusive Disease with Immunodeficiency, Graft Versus Host Disease (GvHD), Bone Marrow Transplant, and Tissue Biopsy.

Michael Grimley is a Hematologist and an Oncologist in Cincinnati, Ohio. Dr. Grimley is rated as a Distinguished provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). His top areas of expertise are Hemophagocytic Lymphohistiocytosis, Graft Versus Host Disease (GvHD), Reticulohistiocytoma, Histiocytosis, and Bone Marrow Transplant.

Julien Zuber practices in Paris, France. Mr. Zuber is rated as a Distinguished expert by MediFind in the treatment of Graft Versus Host Disease (GvHD). His top areas of expertise are Atypical Hemolytic Uremic Syndrome (aHUS), D-Minus Hemolytic Uremic Syndrome, Hemolytic-Uremic Syndrome, Kidney Transplant, and Bone Marrow Transplant.

Maxim Norkin is a Hematologist in Jacksonville, Florida. Dr. Norkin is rated as a Distinguished provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). His top areas of expertise are Acute Myeloid Leukemia (AML), Multiple Myeloma, Myelodysplastic Syndrome (MDS), Bone Marrow Transplant, and Bone Marrow Aspiration.

Michael Maschan practices in Moscow, Russian Federation. Mr. Maschan is rated as a Distinguished expert by MediFind in the treatment of Graft Versus Host Disease (GvHD). His top areas of expertise are Leukemia, Aplastic Anemia, Primary Immunodeficiency (PID), Graft Versus Host Disease (GvHD), and Bone Marrow Transplant.